Home Page - Brooklyn Lung Cancer Conference

The CME-accredited Brooklyn Lung Cancer Conference brings together leading experts in thoracic oncology to provide a comprehensive update on current and emerging strategies for the management of lung cancer, including non–small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The goal of this activity is to enhance the knowledge and clinical competence of learners in applying practice-changing evidence and expert recommendations to optimize outcomes for patients with thoracic malignancies.

The program will feature a combination of didactic presentations and clinically focused discussions highlighting the latest scientific advances in molecular diagnostics, biomarker-driven treatment selection, targeted therapies, and immunotherapy. Faculty will contextualize evolving data within real-world practice, addressing how to incorporate precision oncology approaches, select appropriate therapeutic sequencing, and manage treatment-related toxicities to deliver individualized, evidence-based care.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

New York Marriott at the Brooklyn Bridge